Reducing the diagnostic delay in Antiphospholipid Syndrome over time: a real world observation

BACKGROUND: Antiphospholipid Syndrome (APS) is a rare autoimmune disorder with an estimated prevalence of 40–50 cases per 100.000 persons. Patients suffering from low prevalence diseases are more likely to face diagnostic challenges, given the limited knowledge of most clinicians. The main aim of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Radin, Massimo, Foddai, Silvia Grazietta, Barinotti, Alice, Cecchi, Irene, Rubini, Elena, Sciascia, Savino, Roccatello, Dario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8207757/
https://www.ncbi.nlm.nih.gov/pubmed/34134750
http://dx.doi.org/10.1186/s13023-021-01906-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8207757/
https://www.ncbi.nlm.nih.gov/pubmed/34134750
http://dx.doi.org/10.1186/s13023-021-01906-1

Ejemplares similares